TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells (Q42271141)

19 October 2017

title

TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells (English)

1 reference

19 October 2017

0 references

3

1 reference

19 October 2017

Patrice H Lalive

1

1 reference

19 October 2017

Mahdia Benkhoucha

2

1 reference

19 October 2017

Mario Kreutzfeldt

4

1 reference

19 October 2017

Doron Merkler

5

1 reference

19 October 2017

Marie-Laure Santiago-Raber

6

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

European Journal of Immunology

19 October 2017

published in

1 reference

19 October 2017

volume

44

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

46-57

1 reference

Pathogen recognition with Toll-like receptors

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

A Tlr7 translocation accelerates systemic autoimmunity in murine lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Nucleic acid sensing Toll-like receptors in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

TLR-activated B cells suppress T cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Regulatory molecules required for nucleotide-sensing Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

The role of Toll-like receptors in immunity against mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

The control of CD4+CD25+Foxp3+ regulatory T cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Environmental triggers of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Microglia: Intrinsic immuneffector cell of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Evaluating the role of Toll-like receptors in diseases of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Toll-like receptors in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

DNA and RNA antibodies in serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

Immunology of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Antibody response in MOG(35-55) induced EAE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201242985

7 January 2021

Identifiers

DOI

10.1002/EJI.201242985

1 reference

19 October 2017

1 reference